P6.11 PHOSPHODIESTERASE TYPE-5 INHIBITOR USE IN TYPE 2 DIABETES IS ASSOCIATED WITH A REDUCTION IN ALL CAUSE MORTALITY

S. Anderson; D. Hutchings; C. Kwok; A. Trafford; A. Heald

doi:10.1016/j.artres.2014.09.162

<Previous Article In Issue

Next Article In Issue>

Volume 8, Issue 4, December 2014, Pages 148 - 148

P6.11 PHOSPHODIESTERASE TYPE-5 INHIBITOR USE IN TYPE 2 DIABETES IS ASSOCIATED WITH A REDUCTION IN ALL CAUSE MORTALITY

Authors

S. Anderson^a, D. Hutchings^a, C. Kwok^a, A. Trafford^a, A. Heald^a^{, b}

^aUniversity of Manchester, Manchester, UK

^bLeighton Hospital, Crewe, UK

Available Online 4 November 2014.

DOI: 10.1016/j.artres.2014.09.162 How to use a DOI?
Open Access: This is an open access article distributed under the CC BY-NC license.

Download article (PDF)
View full text (HTML)

<Previous Article In Issue

Next Article In Issue>

Journal: Artery Research
Volume-Issue: 8 - 4
Pages: 148 - 148
Publication Date: 2014/11/04
ISSN (Online): 1876-4401
ISSN (Print): 1872-9312
DOI: 10.1016/j.artres.2014.09.162 How to use a DOI?
Open Access: This is an open access article distributed under the CC BY-NC license.

Cite this article

ris enw bib

TY  - JOUR
AU  - S. Anderson
AU  - D. Hutchings
AU  - C. Kwok
AU  - A. Trafford
AU  - A. Heald
PY  - 2014
DA  - 2014/11/04
TI  - P6.11 PHOSPHODIESTERASE TYPE-5 INHIBITOR USE IN TYPE 2 DIABETES IS ASSOCIATED WITH A REDUCTION IN ALL CAUSE MORTALITY
JO  - Artery Research
SP  - 148
EP  - 148
VL  - 8
IS  - 4
SN  - 1876-4401
UR  - https://doi.org/10.1016/j.artres.2014.09.162
DO  - 10.1016/j.artres.2014.09.162
ID  - Anderson2014
ER  -

download .riscopy to clipboard